Subtle BBB alterations in brain edema associated with acute liver failure

Neurochemistry International

Volumn 56, Issue 1, 2010, Pages 1-2

  Nguyen, Justin H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acute liver failure; Blood brain barrier; Brain edema

Indexed keywords

AMMONIA; AZOXYMETHANE; ENZYME INHIBITOR; EVANS BLUE; GELATINASE B; MONOCLONAL ANTIBODY; WATER;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; BRAIN EDEMA; CELL SWELLING; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL MODEL; EXTRAVASATION; FLUORESCENCE MICROSCOPY; HUMAN; LETTER; LIVER FAILURE; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; NONHUMAN; PATHOGENESIS; PERMEABILITY BARRIER; PRIORITY JOURNAL; TIGHT JUNCTION; ULTRASTRUCTURE;

EID: 73449104202     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.01.008     Document Type: Letter

References (12)

1. Belanger M., Cote J., and Butterworth R.F. Neurobiological characterization of an azoxymethane mouse model of acute liver failure. Neurochem. Int. 48 6-7 (2006) 434-440
2. Gove C.D., Hughes R.D., Ede R.J., and Williams R. Regional cerebral edema and chloride space in galactosamine-induced liver failure in rats. Hepatology 25 2 (1997) 295-301
3. Kato M., Hughes R.D., Keays R.T., and Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology 15 6 (1992) 1060-1066
4. Matkowskyj K.A., Marrero J.A., Carroll R.E., Danilkovich A.V., Green R.M., and Benya R.V. Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model. Am. J. Physiol. 277 2 Pt 1 (1999) G455-G462
5. Nguyen J.H., Yamamoto S., Steers J., Sevlever D., Lin W., Shimojima N., et al. Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice. J. Hepatol. 44 6 (2006) 1105-1114
6. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161 3 (2003) 653-660
7. Nusrat A., Parkos C.A., Verkade P., Foley C.S., Liang T.W., Innis-Whitehouse W., et al. Tight junctions are membrane microdomains. J. Cell Sci. 113 Pt 10 (2000) 1771-1781
8. Potvin M., Finlayson M.H., Hinchey E.J., Lough J.O., and Goresky C.A. Cerebral abnormalities in hepatectomized rats with acute hepatic coma. Lab. Invest. 50 5 (1984) 560-564
9. Sawara K., Desjardins P., Chatauret N., Kato A., Suzuki K., and Butterworth R.F. Alterations in expression of genes coding for proteins of the neurovascular unit in ischemic liver failure. Neurochem. Int. 55 1-3 (2009) 119-123
10. Tavelin S., Hashimoto K., Malkinson J., Lazorova L., Toth I., and Artursson P. A new principle for tight junction modulation based on occludin peptides. Mol. Pharmacol. 64 6 (2003) 1530-1540
11. Traber P.G., Dal Canto M., Ganger D.R., and Blei A.T. Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure: ultrastructure and integrity of the blood-brain barrier. Hepatology 7 6 (1987) 1272-1277
12. Wong V., and Gumbiner B.M. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J. Cell Biol. 136 2 (1997) 399-409